Tarsus (TARS) news
Recent news
Al Tajamouat for Touristic Projects - Acquisition as part of commitment to completing its development and expansion plans
Al Tajamouat for Touristic Projects Company PSC (TAJM), a Jordan-based public shareholding company operating in the real estate development and operations sector, has recently made a strategic acquisition as part of its ongoing commitment to completing its development and expansion plans. The…
AInvest Wire · 1d agoTarsus Pharmaceuticals, Inc.: Barclays reinstates coverage with overweight rating; price target $110
AInvest Wire · Sep 16, 2026Tarsus Pharmaceuticals completes acquisition of Alkeus Pharmaceuticals, expanding leadership in eye care
Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) has completed its acquisition of Alkeus Pharmaceuticals, Inc., a privately held biotechnology company focused on retinal diseases. The transaction, valued at up to $800 million, includes an upfront payment of $450 million, consisting of $270 million in…
AInvest Wire · Sep 4, 2026Tarsus Pharmaceuticals reports oversubscribed $125M placement
AInvest Wire · Aug 6, 2026Tarsus to buy Alkeus for ~$450M upfront in cash and stock
AInvest Wire · Aug 6, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.